Search

Search Constraints

You searched for: Author/Creator Rispens, Theo

Search Results

21. Comparison of Commercially Available Assays for Infliximab Concentrations and Antibodies to Infliximab With Assays Developed at Janssen and Used in Clinical Studies of Remicade®: Iinfliximab in IBD Patients Presidential Poster: 1853. (October 2015)

22. Comprehensive evaluation of microneedle‐based intradermal adalimumab delivery vs. subcutaneous administration: results of a randomized controlled clinical trial. Issue 8 (2nd February 2021)

23. Conserved FcγR- glycan discriminates between fucosylated and afucosylated IgG in humans and mice. (February 2018)

24. Correction: Activated T-Follicular Helper 2 Cells Are Associated With Disease Activity in IgG4-Related Sclerosing Cholangitis and Pancreatitis. Issue 7 (July 2019)

25. COVID-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseases. (May 2022)

26. Disease activity following pregnancy-related discontinuation of natalizumab in MS. Issue 1 (January 2018)

27. Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations. Issue 135 (February 2023)

28. Divergent chemokine receptor expression and the consequence for human IgG4 B cell responses. Issue 8 (25th May 2020)

29. Divergent SARS‐CoV‐2‐specific T‐ and B‐cell responses in severe but not mild COVID‐19 patients. Issue 12 (16th November 2020)

30. Dried blood samples can support monitoring of infliximab concentrations in patients with inflammatory bowel disease: A clinical validation. Issue 7 (11th May 2019)